TFAP4

transcription factor AP-4, the group of Basic helix-loop-helix proteins

Basic information

Region (hg38): 16:4257186-4273075

Links

ENSG00000090447NCBI:7023OMIM:600743HGNC:11745Uniprot:Q01664AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TFAP4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFAP4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
11
clinvar
1
clinvar
12
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 11 0 1

Variants in TFAP4

This is a list of pathogenic ClinVar variants found in the TFAP4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-4258082-C-A not specified Uncertain significance (Mar 06, 2023)2473686
16-4258097-G-C not specified Uncertain significance (Aug 02, 2023)2615211
16-4258101-A-G not specified Uncertain significance (Aug 30, 2022)2309705
16-4258140-T-A not specified Uncertain significance (Mar 29, 2022)2280763
16-4258152-G-T not specified Uncertain significance (May 30, 2024)3325607
16-4260178-G-A not specified Uncertain significance (Aug 13, 2021)3176467
16-4260462-C-T Benign (Oct 17, 2017)776972
16-4260482-C-A not specified Uncertain significance (Apr 15, 2024)3325605
16-4260516-T-G not specified Uncertain significance (Jul 14, 2022)2369738
16-4261915-G-A not specified Uncertain significance (Jun 24, 2022)2345181
16-4262346-G-A not specified Uncertain significance (Jun 29, 2023)2607976
16-4262561-T-C not specified Uncertain significance (May 26, 2024)3325606
16-4262601-T-C not specified Uncertain significance (May 17, 2023)2547900
16-4272701-G-C not specified Uncertain significance (Dec 28, 2023)3176466
16-4272707-A-T not specified Uncertain significance (Mar 13, 2023)2495676

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TFAP4protein_codingprotein_codingENST00000204517 715890
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9970.00269104262021042640.00000959
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.601522180.6960.00001532180
Missense in Polyphen1452.9050.26463457
Synonymous-0.2779793.61.040.00000680676
Loss of Function3.86017.40.009.06e-7182

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00003880.0000388
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.00004150.0000415
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription factor that activates both viral and cellular genes by binding to the symmetrical DNA sequence 5'- CAGCTG-3'.;
Pathway
Proteoglycans in cancer - Homo sapiens (human) (Consensus)

Intolerance Scores

loftool
rvis_EVS
0.08
rvis_percentile_EVS
60.09

Haploinsufficiency Scores

pHI
0.347
hipred
Y
hipred_score
0.728
ghis
0.506

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.797

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tfap4
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cell population proliferation;positive regulation of apoptotic process;negative regulation of DNA binding;negative regulation by host of viral transcription;positive regulation by host of viral transcription;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;protein-containing complex assembly;negative regulation of cell cycle arrest;cellular response to dexamethasone stimulus;regulation of mitotic cell cycle phase transition;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway
Cellular component
nucleus;mitochondrion;transcriptional repressor complex
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;protein homodimerization activity;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;protein heterodimerization activity;E-box binding